Axos Financial, Inc. (AX)
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
$97.95+0.94%
Close 2026-09-04 · 1-day change
NYSEFinancialsBanks - RegionalSnapshot 2026-09-04
QuarterlyIQ Insights · AX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $98 the market pays 1.8× p/b — above the 1.2× p/b peer median but in line with its own 2× history. That premium reflects a durable franchise our peer-anchored $96 fair value understates; treat the 'expensive vs peers' read with medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| graham number | 12M | $103.14 | — | — | TTM | high |
| Peer P/B | 12M | $67.02 | 1.2 | 54.04 | TTM | high |
| Peer P/E | 12M | $107.45 | 10.9 | 9.86 | ntm analyst | high |
| Peer P/S | 12M | $105.33 | 3.2 | 33.33 | TTM | high |
| PEG | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Around its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
| $203.24 |
| 23.2 |
| 8.75 |
| TTM |
| high |
| residual income | 12M | $66.57 | — | — | TTM | high |
| Own P/E history | 12M | $96.87 | 11.1 | 8.75 | TTM | high |
| triangulated | 12M | $107.43 | 11.9 | 8.99 | Triangulated | high |
| Peer P/B | 3Y | $101.93 | 1.2 | 82.18 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $113.63 | 10.9 | 10.43 | Analyst | medium |
| Peer P/S | 3Y | $96.89 | 3.2 | 30.66 | Analyst | medium |
| PEG | 3Y | $242.28 | 23.2 | 10.43 | Analyst | medium |
| Own P/E history | 3Y | $115.48 | 11.1 | 10.43 | Analyst | medium |
| Peer P/B | 5Y | $134.80 | 1.2 | 108.69 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $107.47 | 10.9 | 9.87 | Analyst | high |
| Peer P/S | 5Y | $91.64 | 3.2 | 29.00 | Analyst | high |
| PEG | 5Y | $229.16 | 23.2 | 9.87 | Analyst | high |
| Own P/E history | 5Y | $109.23 | 11.1 | 9.87 | Analyst | high |